Abstract
The case of a 5 year old male is described who had acute myeloblastic leukaemia (AML M5) and was in third remission when he underwent an allogeneic T cell depleted bone marrow transplantation (BMT). The bone marrow was from an HLA matched unrelated donor (MUD) who suffered from chronic idiopathic thrombocytopenic purpura (ITP). In spite of this, the patient had rapid platelet engraftment post BMT (>50×109 1−1 on day 20). He is now 12 months post-transplantation and has normal platelet counts, without any clinical or laboratory evidence of ITP. Autoimmune manifestations such as ITP occurring in bone marrow recipients following BMT have been previously reported. Furthermore, severe and protracted thrombocytopenia is a known complication following MUD transplantation and with its respective high risk of graftversus host disease (GVHD). In this case, no signs of ITP could be detected in the recipient despite the fact that the donor had ITP. Our data suggest that in the absence of an alternative choice, a person with ITP should be considered as an appropriate donor for transplantation.
Similar content being viewed by others
References
First, L.R., Smith, B.R., Lipton, J.et al. (1985) Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes.Blood 65, 368–74.
Katayama, N., Oda, K., Furuta, I.et al. (1988) Autoimmune thrombocytopenia after allogeneic bone marrow transplantation.Acta Haematol. 51, 137–41.
Spruce, W., Forman, S., McMillan, R.et al. (1983) Idiopathic thrombocytopenic purpura following bone marrow transplantation.Acta Haematol. 69, 47–51.
Munchinton, R.M., Waters, A.H., Malpas, J.S.et al. (1984) Platelet and granulocyte-specific antibodies after allogeneic and autologous bone marrow grafts.Vox Sang 46, 125–33.
Klumpp, T.R., Caligiuri, M.A., Rabinowe, S.N.et al. (1990) Autoimmune pancytopenia following allogeneic bone marrow transplantation.Bone Marrow Transpl. 46, 445–7.
Shulman, H.M. and Sullivan, K.M. (1988) Graft-versus-host disease: allo- and autoimmunity after bone marrow transplantation. In J.M. Cruse and R.E. Lewis (eds) Cellular Aspects of Autoimmunity, pp. 141–65. Karger: Basel-Sydney.
Ansetti, C., Rybka, W., Sullivan, K.M.et al. (1989) Graft-Versus-Host Disease is associated with autoimmune-like thrombocytopenia.Blood 73, 1054–61.
Kernan, N., Bartsch, G., Ash, R.C.et al. (1993) Analysis of 462 transplantations from unrelated donors facilitated by the National Bone Marrow Program.New Eng. J. Med. 328, 593–602.
Marks, D.I., Cullis, J.O., Ward, K.N.et al. (1993) Allogeneic bone marrow transplantation for chronic myeloid leukaemia using siblings and volunteer unrelated donors.Ann. Int. Med. 119, 207–14.
Smith, U.E., Biberfeld, R.L., Christensen, B.et al. (1988) Myasthenia gravis after bone marrow transplantation: evidence for a donor origin.New Eng. J. Med. 309, 1565–8.
Aldouri, M.A., Ruggier, R., Epstein, O. and Prentice, H.G. (1990) Adoptive transfer of hyperthyroidism and autoimmune thyroiditis following allogeneic bone marrow transplantation for chronic myeloid leukaemia.Br. J. Haematol. 74, 118–9.
Marmont, A.M. (1992) Autoimmunity and allogeneic bone marrow transplantation.Bone Marrow Transpl. 9, 1–3.
Minchinton, R.M., Wates, A., Kendra, J. and Barrett, A.J. (1982) Autoimmune thrombocytopenia acquired from an allogeneic bone marrow graft.Lancet 2, 627–32.
Karussis, D.M., Slavin, S., Lehmann, D.et al. (1992) Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation.J. Immunol. 148, 1693–8.
Slavin, S., Karussis, D.M., Weiss, L.et al. (1993) Immunohematopoietic reconstitution by allogeneic and autologous bone marrow grafts as a means for induction and specific unresponsiveness to donor-specific allografts and modified self in autoimmune disorders.Transpl. Proc. 25, 1274–5.
Karussis, D.M., Vourka-Karussis, U., Ovadia, H.et al. (1993) Prevention and reversal of adoptively transferred chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE) with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation.J. Clin. Invest. 92, 765–72.
Slavin, S. (1993) Treatment of life threatening autoimmune diseases with myeloablative doses of immunosuppressive agents and autologous bone marrow transplantation-rationale and experimental background.Bone Marrow Transpl. 12, 85–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Delukina, M., Kapelushnik, Y., Or, R. et al. Successful matched unrelated transplantation from a donor with idiopathic thrombocytopenic purpura (ITP). Med Oncol 12, 125–127 (1995). https://doi.org/10.1007/BF01676714
Issue Date:
DOI: https://doi.org/10.1007/BF01676714